David Chaim Rubinsztein (born 1963) is the Deputy Director of the Cambridge Institute of Medical Research (CIMR),[5] Professor of Molecular Neurogenetics at the University of Cambridge[6] and a UK Dementia Research Institute Professor.
[7] In 1997, Rubinsztein acquired his Certificate of Completion of Specialist Training at the University of Cambridge.
In 2005, he was promoted to Professor of Molecular Neurogenetics at the University of Cambridge (personal chair).
[10][11][12] Rubinsztein has made major contributions to the field of neurodegeneration[4] with his laboratory's discovery that autophagy regulates the levels of intracytoplasmic aggregate-prone proteins that cause many neurodegenerative diseases, including Huntington's, Parkinson's and Alzheimer's disease.
He is currently focused on understanding how to induce autophagy in vivo to remove toxic proteins and avoid the development of neurodegenerative disease[5][25] Rubinsztein has won numerous awards including: